Aebersold Sarah's Form 4 filing
Biolife Solutions Inc (BLFS) · filed Mar 13, 2025
- Accession no.
- 0001628280-25-012680
- Filed
- Mar 13, 2025
- Trade date
- Mar 11-12, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $220.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Aebersold SarahCIK 0001837756 | Officer (Chief Human Resources Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2025 | Common Stock | SSaleDisposed | −1,091 | $25.00 | −$27,275 | 58,816 | Direct | |
| Mar 12, 2025 | Common Stock | SSaleDisposed | −7,324 | $26.34 | −$192,914.16 | 51,492 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.